HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

LONGBIO-B

106.000

-8.300-7.26%

Volume:371.00K

Turnover:40.14M

Market Cap:8.09B

PE:-34.20

High:116.300

Open:113.000

Low:101.500

Close:114.300

52wk High:165.900

52wk Low:72.650

Shares:76.32M

HK Float Shares:75.06M

Volume Ratio:0.67

T/O Rate:0.49%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-3.100

ROE:--

ROA:-54.56%

PB:6.14

PE(LYR):-34.20

PS:2745.86

Loading ...

Overview Company News Filings

LongBio Pharma Updates Board Structure and Committee Assignments

Bulletin Express

Longbio Pharma Files Board, Board Committee Member List for Disclosure Responsibilities

LongBio Pharma Names Xue Kailu Non-Executive Director After EGM Vote

LONGBIO-B (01779) Added to Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect Lists

LongBio Pharma Added to Shanghai, Shenzhen-Hong Kong Stock Connect Eligible Lists

Longbio Pharma Files Board, Board Committee Member List with Disclosure Roles

LongBio Pharma proposes board reshuffle and initiates H-share full circulation

Bulletin Express

LongBio Pharma Schedules 10 September 2026 EGM to Appoint Non-Executive Director

Bulletin Express

Longbio Pharma Announces Extraordinary General Meeting

LongBio Pharma Names Xue Kailu as Non-Executive Director, Replacing Chen Kan

LONGBIO-B Reports Interim Loss of RMB 135 Million, Widening by 43.1% Year-on-Year

LongBio Pharma: BLA Filed for Core Anti-IgE Drug as R&D Spend Jumps 61% and IPO Lifts Cash to RMB1.21 Billion

Bulletin Express

LongBio Pharma FY26 H1 Net Loss Widens 43.1% to RMB 134.81 Million

LongBio Pharma's Allergic Rhinitis Drug Application Accepted in China

MT Newswires Live

LongBio Pharma’s LP-003 BLA for Seasonal Allergic Rhinitis Accepted by China’s NMPA

Bulletin Express

LONGBIO-B's Key Allergy Drug Candidate LP-003 Receives Regulatory Acceptance for Seasonal Allergic Rhinitis

LongBio Pharma Says China Regulator Accepts LP-003 BLA for Seasonal Allergic Rhinitis

Longbio Pharma (Suzhou) Co - Nmpa Accepts Bla for Lp-003 for Seasonal Allergic Rhinitis

THOMSON REUTERS

LongBio Pharma Sets 21 August 2026 Board Meeting to Review 1H26 Results and Potential Dividend

Bulletin Express

LongBio Pharma Sets Board Meeting to Review Interim Results, Consider Dividend

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/01779/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01779","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01779\",,,,,undefined,":{"symbol":"01779","market":"HK","secType":"STK","nameCN":"LONGBIO-B","latestPrice":106,"timestamp":1789027722082,"preClose":114.3,"halted":0,"volume":371000,"delay":0,"changeRate":-0.07261592300962377,"floatShares":75059200,"shares":76322100,"eps":-3.099834,"marketStatus":"Closed","change":-8.3,"latestTime":"09-10 16:08:42","open":113,"high":116.3,"low":101.5,"amount":40140055,"amplitude":0.129484,"askPrice":106.9,"askSize":500,"bidPrice":106,"bidSize":6950,"shortable":0,"etf":0,"ttmEps":-3.261,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":5,"adr":0,"listingDate":1780588800000,"exchange":"SEHK","adjPreClose":114.3,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":0.670624,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01779\",,,,,undefined,":{"symbol":"01779","floatShares":75059200,"roa":"-54.56%","roe":"--","lyrEps":-3.099834,"volumeRatio":0.670624,"shares":76322100,"dividePrice":0,"high":116.3,"amplitude":0.129484,"preClose":114.3,"low":101.5,"week52Low":72.65,"pbRate":"6.14","psRate":"2745.86","week52High":165.9,"institutionHeld":0,"latestPrice":106,"committee":0.865772,"eps":-3.099834,"divideRate":0,"volume":371000,"delay":0,"ttmEps":-3.261,"open":113,"prevYearClose":96.06,"prevWeekClose":128,"prevMonthClose":121.6,"prevQuarterClose":150.9,"fiveDayClose":123,"twentyDayClose":128.2,"sixtyDayClose":142.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01779\",params:#limit:5,,,undefined,":[{"date":"2026-08-21","symbol":"01779","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787275800000,"name":null,"time":"","dateTimestamp":1787241600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01779\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01779\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":1,"updateTime":1784563200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01779\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01779","date":"2026-09-09","current":-32.505366,"percent":0.765625,"low":-57.574283,"twenty":-51.032369,"median":-38.724662,"eighty":-33.184176,"high":-30.168259,"avg":-40.879005,"sd":8.09294,"marketCap":8480277045},"quantilePoints":[{"date":"2026-06-12","current":-52.571631,"twenty":-51.987096,"median":-51.066007,"eighty":-49.243383,"marketCap":10676394285},{"date":"2026-06-18","current":-52.044895,"twenty":-52.077848,"median":-51.840962,"eighty":-50.705966,"marketCap":10594781820},{"date":"2026-06-26","current":-54.937294,"twenty":-55.921485,"median":-52.086085,"eighty":-51.049188,"marketCap":11128972500},{"date":"2026-07-03","current":-38.82993,"twenty":-55.511514,"median":-52.086085,"eighty":-50.54697,"marketCap":7871893215},{"date":"2026-07-10","current":-35.616464,"twenty":-55.275063,"median":-51.840962,"eighty":-39.024704,"marketCap":7211574180},{"date":"2026-07-17","current":-31.236455,"twenty":-55.113833,"median":-50.626468,"eighty":-33.702374,"marketCap":6347223982},{"date":"2026-07-24","current":-32.543593,"twenty":-53.991029,"median":-39.576969,"eighty":-32.682309,"marketCap":6614319322},{"date":"2026-07-31","current":-35.105215,"twenty":-52.48276,"median":-38.82993,"eighty":-32.450461,"marketCap":7148510002},{"date":"2026-08-07","current":-41.09187,"twenty":-52.1108,"median":-38.793333,"eighty":-32.612951,"marketCap":8383825950},{"date":"2026-08-14","current":-43.58221,"twenty":-52.013269,"median":-39.316865,"eighty":-32.896956,"marketCap":8903178000},{"date":"2026-08-21","current":-41.637947,"twenty":-51.877603,"median":-40.334419,"eighty":-32.925453,"marketCap":8524792935},{"date":"2026-08-28","current":-38.51868,"twenty":-51.685971,"median":-39.316865,"eighty":-33.000323,"marketCap":9711883335},{"date":"2026-09-04","current":-37.65021,"twenty":-51.057597,"median":-38.793333,"eighty":-33.119015,"marketCap":9496723200},{"date":"2026-09-09","current":-33.566738,"twenty":-51.032369,"median":-38.724662,"eighty":-33.184176,"marketCap":8480277045}],"updateTime":1789045995774},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01779\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1116580055","title":"LongBio Pharma Updates Board Structure and Committee Assignments","url":"https://stock-news.laohu8.com/highlight/detail?id=1116580055","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116580055?lang=en_us&edition=fundamental","pubTime":"2026-09-10 21:04","pubTimestamp":1789045440,"startTime":"0","endTime":"0","summary":"LongBio Pharma (Suzhou) Co., Ltd. released an announcement on 10 September 2026 detailing the latest composition of its Board of Directors and the memberships of its three standing committees. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666659546","title":"Longbio Pharma Files Board, Board Committee Member List for Disclosure Responsibilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2666659546","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666659546?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:52","pubTimestamp":1789044751,"startTime":"0","endTime":"0","summary":"Longbio Pharma files board, board committee member list for disclosure responsibilitiesLongbio Pharma disclosed its board lineup, confirming Liu Heng as chairman alongside executive directors Sun Naic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL8Wwkfc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666934595","title":"LongBio Pharma Names Xue Kailu Non-Executive Director After EGM Vote","url":"https://stock-news.laohu8.com/highlight/detail?id=2666934595","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666934595?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:46","pubTimestamp":1789044388,"startTime":"0","endTime":"0","summary":"LongBio Pharma names Xue Kailu non-executive director after EGM voteLongbio Pharma shareholders elected Xue Kailu as a non-executive director at an extraordinary general meeting on Sept. 10, 2026.The ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL3T0Rkc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163275720","title":"LONGBIO-B (01779) Added to Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect Lists","url":"https://stock-news.laohu8.com/highlight/detail?id=1163275720","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163275720?lang=en_us&edition=fundamental","pubTime":"2026-09-07 22:00","pubTimestamp":1788789617,"startTime":"0","endTime":"0","summary":"LONGBIO-B (01779) announced its inclusion in the eligible securities lists under both the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs, taking effect from September...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665931252","title":"LongBio Pharma Added to Shanghai, Shenzhen-Hong Kong Stock Connect Eligible Lists","url":"https://stock-news.laohu8.com/highlight/detail?id=2665931252","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665931252?lang=en_us&edition=fundamental","pubTime":"2026-09-07 21:57","pubTimestamp":1788789424,"startTime":"0","endTime":"0","summary":"LongBio Pharma added to Shanghai, Shenzhen-Hong Kong Stock Connect eligible listsLongBio Pharma was added to the eligible securities lists for Shanghai-Hong Kong Stock Connect, effective Sept. 7, 2026","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL9wtzPy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663079505","title":"Longbio Pharma Files Board, Board Committee Member List with Disclosure Roles","url":"https://stock-news.laohu8.com/highlight/detail?id=2663079505","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663079505?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:38","pubTimestamp":1788169132,"startTime":"0","endTime":"0","summary":"Longbio Pharma files board, board committee member list with disclosure rolesLongbio Pharma updated its board and committee lineup on Aug. 31, 2026, naming Liu Heng as chairman.Executive directors: Li","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL6Hs4Dr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134828489","title":"LongBio Pharma proposes board reshuffle and initiates H-share full circulation","url":"https://stock-news.laohu8.com/highlight/detail?id=1134828489","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134828489?lang=en_us&edition=fundamental","pubTime":"2026-08-21 22:51","pubTimestamp":1787323887,"startTime":"0","endTime":"0","summary":"LongBio Pharma (Suzhou) Co., Ltd. has announced two key corporate moves: a planned change in its non-executive directorship and the launch of an H-share full-circulation programme. Non-executive...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134108727","title":"LongBio Pharma Schedules 10 September 2026 EGM to Appoint Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1134108727","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134108727?lang=en_us&edition=fundamental","pubTime":"2026-08-21 22:48","pubTimestamp":1787323725,"startTime":"0","endTime":"0","summary":"LongBio Pharma (Suzhou) Co., Ltd. has called an extraordinary general meeting (EGM) for 10 September 2026 at 16:00 (Beijing time) in Room 302, Building 88, No. 887 Zuchongzhi Road, Zhangjiang...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661296512","title":"Longbio Pharma Announces Extraordinary General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2661296512","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661296512?lang=en_us&edition=fundamental","pubTime":"2026-08-21 22:22","pubTimestamp":1787322158,"startTime":"0","endTime":"0","summary":"Longbio Pharma announces extraordinary general meetingLongBio Pharma will hold an extraordinary general meeting in Shanghai, China on Sept. 10, 2026.Shareholders will vote on appointing Xue Kailu as a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL4Rhx9Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661295018","title":"LongBio Pharma Names Xue Kailu as Non-Executive Director, Replacing Chen Kan","url":"https://stock-news.laohu8.com/highlight/detail?id=2661295018","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661295018?lang=en_us&edition=fundamental","pubTime":"2026-08-21 22:15","pubTimestamp":1787321743,"startTime":"0","endTime":"0","summary":"LongBio Pharma names Xue Kailu as non-executive director, replacing Chen KanLongBio Pharma (Suzhou) set a non-executive director change, with Chen Kan to step down effective Aug. 31, 2026.Shareholders","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL37Rjsg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190762326","title":"LONGBIO-B Reports Interim Loss of RMB 135 Million, Widening by 43.1% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1190762326","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190762326?lang=en_us&edition=fundamental","pubTime":"2026-08-21 17:51","pubTimestamp":1787305865,"startTime":"0","endTime":"0","summary":"LONGBIO-B (01779) has released its interim results for the six months ended June 30, 2026, revealing a net loss attributable to shareholders of RMB 135 million, a 43.1% increase from the same period...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149133091","title":"LongBio Pharma: BLA Filed for Core Anti-IgE Drug as R&D Spend Jumps 61% and IPO Lifts Cash to RMB1.21 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1149133091","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149133091?lang=en_us&edition=fundamental","pubTime":"2026-08-21 17:46","pubTimestamp":1787305562,"startTime":"0","endTime":"0","summary":"LongBio Pharma (Suzhou) Co., Ltd. (LONGBIO-B) reported interim 2026 results showing accelerated pipeline progress and a substantially strengthened balance sheet following its Hong Kong IPO. Pipeline...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"LongBio Pharma: BLA Filed for Core Anti-IgE Drug as R&D Spend Jumps 61% and IPO Lifts Cash to RMB1.21 Billion","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661269135","title":"LongBio Pharma FY26 H1 Net Loss Widens 43.1% to RMB 134.81 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2661269135","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661269135?lang=en_us&edition=fundamental","pubTime":"2026-08-21 17:43","pubTimestamp":1787305432,"startTime":"0","endTime":"0","summary":"LongBio Pharma FY26 H1 net loss widens 43.1% to RMB 134.81 millionLongBio Pharma posted a net loss of RMB 134.81 million, widening 43.1% from a year earlier.R&D costs climbed 60.8% to RMB 108.23 milli","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL37vlkp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661687142","title":"LongBio Pharma's Allergic Rhinitis Drug Application Accepted in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2661687142","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661687142?lang=en_us&edition=fundamental","pubTime":"2026-08-21 15:53","pubTimestamp":1787298808,"startTime":"0","endTime":"0","summary":"LongBio Pharma (Suzhou)'s (HKG:1779) biologics license application for LP-003 was accepted by China's National Medical Products Administration.The acceptance is for the indication of seasonal allergic rhinitis, according to a Friday Hong Kong bourse filing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125738268","title":"LongBio Pharma’s LP-003 BLA for Seasonal Allergic Rhinitis Accepted by China’s NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=1125738268","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125738268?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:45","pubTimestamp":1787265908,"startTime":"0","endTime":"0","summary":"Hong Kong–listed biopharmaceutical firm LongBio Pharma (LONGBIO-B) announced that the National Medical Products Administration (NMPA) has formally accepted its biologics license application (BLA) for...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187233290","title":"LONGBIO-B's Key Allergy Drug Candidate LP-003 Receives Regulatory Acceptance for Seasonal Allergic Rhinitis","url":"https://stock-news.laohu8.com/highlight/detail?id=1187233290","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187233290?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:26","pubTimestamp":1787264777,"startTime":"0","endTime":"0","summary":"LONGBIO-B (01779) has announced that the Biologics License Application (BLA) for LP-003, targeting the indication of seasonal allergic rhinitis, has been formally accepted for review by China's...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661230121","title":"LongBio Pharma Says China Regulator Accepts LP-003 BLA for Seasonal Allergic Rhinitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2661230121","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661230121?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:18","pubTimestamp":1787264308,"startTime":"0","endTime":"0","summary":"LongBio Pharma says China regulator accepts LP-003 BLA for seasonal allergic rhinitisLongBio Pharma’s China regulator accepted a BLA for LP-003 to treat seasonal allergic rhinitis.LP-003 is an anti-Ig","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL8Qkbzf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661230114","title":"Longbio Pharma (Suzhou) Co - Nmpa Accepts Bla for Lp-003 for Seasonal Allergic Rhinitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2661230114","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661230114?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:17","pubTimestamp":1787264226,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nFWN44H1HU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177059964","title":"LongBio Pharma Sets 21 August 2026 Board Meeting to Review 1H26 Results and Potential Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1177059964","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177059964?lang=en_us&edition=fundamental","pubTime":"2026-08-11 18:23","pubTimestamp":1786443829,"startTime":"0","endTime":"0","summary":"LongBio Pharma (Suzhou) Co., Ltd. has scheduled a board meeting for Friday, 21 August 2026. The agenda includes approval of the unaudited interim results for the six months ended 30 June 2026 and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01779"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658529999","title":"LongBio Pharma Sets Board Meeting to Review Interim Results, Consider Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2658529999","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658529999?lang=en_us&edition=fundamental","pubTime":"2026-08-11 17:53","pubTimestamp":1786442008,"startTime":"0","endTime":"0","summary":"LongBio Pharma sets board meeting to review interim results, consider dividendLongBio Pharma (Suzhou) schedules a board meeting for Aug. 21, 2026 to review the unaudited interim results for the six mo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL8THjwX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","01779"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":63,"code":"91000000","status":"200"}]}}